Abemaciclib 150 mg Tablets is a targeted anti-cancer medication used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. It belongs to the class of CDK4/6 inhibitors, which help block cancer cell growth and division.
It is commonly prescribed alone or in combination with hormone therapy such as fulvestrant or aromatase inhibitors to improve survival outcomes.
⚙️ How Abemaciclib Works
Abemaciclib works by:
-
Inhibiting Cyclin-Dependent Kinases 4 and 6 (CDK4/6)
-
Stopping cancer cell cycle progression
-
Slowing tumor growth and spread
-
Enhancing effectiveness of hormone therapy
🩺 Uses of Abemaciclib 150 mg Tablets
-
HR-positive, HER2-negative breast cancer
-
Advanced or metastatic breast cancer
-
Breast cancer resistant to hormone therapy
-
Combination therapy with endocrine treatments
💡 Benefits of Abemaciclib 150 mg
-
Slows cancer cell growth
-
Improves progression-free survival
-
Effective oral targeted therapy
-
Reduces tumor progression risk
-
Suitable for long-term cancer management
📌 Dosage & Administration
-
Usually taken twice daily or as prescribed
-
Can be taken with or without food
-
Swallow tablet whole — do not crush
-
Dose adjustments based on tolerance and side effects
⚠ Follow oncologist instructions strictly.
⚠️ Possible Side Effects
-
Diarrhea
-
Fatigue
-
Nausea or vomiting
-
Loss of appetite
-
Low white blood cell count
-
Liver enzyme changes
Seek medical help if severe symptoms occur.
🚫 Precautions & Warnings
-
Prescription-only oncology drug
-
Monitor blood counts and liver function
-
Avoid during pregnancy and breastfeeding
-
Inform doctor about liver or kidney issues
-
Use effective contraception during treatment
🏥 Storage Instructions
-
Store below 25°C
-
Keep away from heat and moisture
-
Keep out of reach of children
📦 Packaging Details
-
Strength: 150 mg
-
Dosage Form: Film-Coated Tablet
-
Manufacturer: Lilly
-
Pack Size: 7×2 Tablets
Reviews
There are no reviews yet.